Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis

RTTNews | 1595 hari yang lalu
Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis

(RTTNews) - Arcutis Biotherapeutics, Inc. (ARQT) announced Monday that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and adolescents. The target action date is April 30, 2023.

Roflumilast cream (ARQ-151) is a once-daily topical formulation of roflumilast, a highly potent and selective inhibitor of phosphodiesterase type 4 (PDE4), an enzyme that drives overactive immune responses. PDE4 is an established target in dermatology.

Arcutis' NDS submission is supported by positive data from Arcutis' pivotal Phase 3 program and two long-term open label studies. DERMIS-1 and DERMIS-2 were identical Phase 3 randomized, parallel, double-blind, vehicle-controlled, multi-national, multi-center studies to evaluate the safety and efficacy of roflumilast cream 0.3%.

A new drug application (NDA) for roflumilast cream for the treatment of plaque psoriasis in adolescents and adults is also under review by the U.S. Food & Drug Administration (FDA). The FDA has set a target action date of July 29, 2022.

For More Such Health News, visit rttnews.com

baca selengkapnya
Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO

Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO

Medical dermatology company Arcutis Biotherapeutics, Inc. (ARQT) announced Wednesday that David Topper has been appointed Chief Financial Officer (CFO) effective April 10, 2024. Topper is replacing John Smither, who rejoined Arcutis as interim CFO in August 2023. Smither will remain at Arcutis through the end of April to ensure a smooth transition.
RTTNews | 956 hari yang lalu
Swiss Market Ends Weak For 4th Straight Session

Swiss Market Ends Weak For 4th Straight Session

The Switzerland market ended weak on Friday, extending recent losses, as rising uncertainty about AI trade and rising cost of debts, as well as fears of possible interest rate hikes by central banks rendered the mood bearish.
RTTNews | 2 hari yang lalu
European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European stocks fell on Friday and several markets across the region hit multi-week lows - some markets even dropped to multi-month lows - weighed down by losses in several sectors, especially in the technology space amid uncertainty about the sustainability of AI trade despite Anthropic's historic IPO.
RTTNews | 2 hari yang lalu
TSX Sinks To 6-Month Low As Tech Sector Crumbles

TSX Sinks To 6-Month Low As Tech Sector Crumbles

Canadian equities tumbled Friday as technology stocks plunged 4.4% following global AI trade concerns. The benchmark index dropped 418.25 points to 33,610.48. Materials and financial sectors also declined significantly on weak commodity prices.
RTTNews | 2 hari yang lalu
U.S. Consumer Sentiment Improves More Than Previously Estimated November

U.S. Consumer Sentiment Improves More Than Previously Estimated November

A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by more than previously estimated in the month of November. The University of Michigan said its consumer sentiment index for November was upwardly revised to 51.5 from a preliminary reading of 51.0.
RTTNews | 2 hari yang lalu
Euro Falls Amid Risk-Off Mood

Euro Falls Amid Risk-Off Mood

The euro weakened against other major currencies in the European session on Friday, as European stocks traded lower due to ongoing sell-off in artificial intelligence and chip stocks.
RTTNews | 2 hari yang lalu